| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cb1ea8a5e9598ecc016ec93c2183787 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02E60-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01M2004-8684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01M2008-1293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-009 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01M4-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01M4-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01M8-0247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01M4-8657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01M8-023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01M4-8642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-08 |
| filingDate |
2006-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b5d723794eaa72828f6a0f85fa3506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc214a3c8f3daf1f53bb7e331b3070b6 |
| publicationDate |
2019-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3546000-A1 |
| titleOfInvention |
Nasal administration |
| abstract |
A delivery device for delivery of substance to the central nervous system (CNS) of a subject, the delivery device comprising: a nosepiece unit for insertion into a nasal airway of a subject and comprising an outlet unit which includes a nozzle for delivering substance into the nasal airway of the subject; and a substance supply unit which is operable to deliver a dose of substance to the nozzle; wherein the delivery device is configured such that at least 30 % of the dose as initially deposited in the nasal airway is deposited in an upper posterior region of the nasal airway, thereby providing a CNS concentration of the substance, and hence CNS effect, which is significantly greater than that which would be predicted from a counterpart blood plasma concentration of the substance. Sumatriptan or its pharmaceutically-acceptable derivatives or analogues for use in the treatment of migraine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108404267-A |
| priorityDate |
2006-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |